Skip to main content

Table 1 Clinicopathological data for MSI+ CRCs analyzed in-lab

From: Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1

Clinicopathological parameters Norwegian series I (n = 78) Norwegian series II (n = 31) VICTOR (n = 81)
All patients Exome sequenced (n = 33)
Patient age at diagnosis (years)
 Mean 75 74 66 65
 Min 37 37 26 38
 Max 93 93 92 89
Patient gender
 Female 55 23 18 45
 Male 23 10 13 36
Tumor localization
 Right 68 31 20 66
 Left 6 1 7 13
 Rectum 4 1 4 -
 Unknown - - - 2
Tumor stage
 I 16 1 3 -
 II 42 23 17 54
 III 15 9 8 27
 IV 5 - 3 -
5-year survival rates
 Overall 71% 85% 83% 82%
 Relapse-free 70% 82% 72% NA
  1. NA not available
\